Glucocorticoid sensitivity of leukocytes predicts PTSD, depressive and fatigue symptoms after military deployment: A prospective study

Psychoneuroendocrinology

Volumn 37, Issue 11, 2012, Pages 1822-1836

  van Zuiden, Mirjam ^a,b,c   Heijnen, Cobi J ^a   Maas, Mirjam ^a   Amarouchi, Karima ^a   Vermetten, Eric ^b,d   Geuze, Elbert ^b,d   Kavelaars, Annemieke ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Ministerie van Defensie   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Dexamethasone; Fatigue; Glucocorticoid receptor; Leukocytes; Longitudinal; MDD; Monocytes; PTSD; T cells; Vulnerability

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AFGHANISTAN; ARTICLE; CHILDHOOD INJURY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FATIGUE; HUMAN; HUMAN CELL; LOGISTIC REGRESSION ANALYSIS; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MILITARY DEPLOYMENT; MONOCYTE; POSTTRAUMATIC STRESS DISORDER; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SYMPTOM; T LYMPHOCYTE;

ADULT; AFGHAN CAMPAIGN 2001-; DEPRESSION; DEXAMETHASONE; FATIGUE; GLUCOCORTICOIDS; HUMANS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MALE; MILITARY PERSONNEL; MONOCYTES; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; RECEPTORS, GLUCOCORTICOID; STRESS DISORDERS, POST-TRAUMATIC; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84866333122     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2012.03.018     Document Type: Article

References (62)

1. Aben I., Verhey F., Lousberg R., Lodder J., Honig A. Validity of the Beck Depression Inventory, Hospital Anxiety and Depression Scale SCL-90, and Hamilton Depression Rating Scale as screening instruments for depression in stroke patients. Psychosomatics 2002, 43:386-393.
2. Armanini D., Karbowiak I., Scali M., Orlandini E., Zampollo V., Vittadello G. Corticosteroid receptors and lymphocyte subsets in mononuclear leukocytes in aging. Am. J. Physiol. 1992, 262:E464-E466.
3. Armanini D., Spinella P., Simoncini M., Basso A., Zovato S., Pozzan G.B., De Palo C.B., Bucciante G., Karbowiak I. Regulation of corticosteroid receptors in patients with anorexia nervosa and Cushing's syndrome. J. Endocrinol. 1998, 158:435-439.
4. Arnold L.M. Understanding fatigue in major depressive disorder and other medical disorders. Psychosomatics 2008, 49:185-190.
5. Arrindell W.A., Ettema J.H.M. Symptom Checklist: Handleiding Bij Een Multidimensionele Psychopathologie-Indicator (Symptom Checklist: Manual for a Multidimensional Indicator of Psychopathology) 2003, Swets & Zeitlinger, Lisse, The Netherlands.
6. Bauer M.E., Papadopoulos A., Poon L., Perks P., Lightman S.L., Checkley S., Shanks N. Dexamethasone-induced effects on lymphocyte distribution and expression of adhesion molecules in treatment-resistant depression. Psychiatry Res. 2002, 113:1-15.
7. Bauer M.E., Papadopoulos A., Poon L., Perks P., Lightman S.L., Checkley S., Shanks N. Altered glucocorticoid immunoregulation in treatment resistant depression. Psychoneuroendocrinology 2003, 28:49-65.
8. Bremner J.D., Bolus R., Mayer E.A. Psychometric properties of the early trauma inventory - self report. J. Nerv. Ment. Dis. 2007, 195:211-218.
9. Brewin C.R., Andrews B., Valentine J.D. Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. J. Consult. Clin. Psychol. 2000, 68:748-766.
10. Buckingham J.C. Glucocorticoids: exemplars of multi-tasking. Br. J. Pharmacol. 2006, 147:258-268.
11. Capuron L., Miller A.H. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol. Ther. 2011, 130:226-238.
12. Carvalho L.A., Juruena M.F., Papadopoulos A.S., Poon L., Kerwin R., Cleare A.J., Pariante C.M. Clomipramine in vitro reduces glucocorticoid receptor function in healthy subjects but not in patients with major depression. Neuropsychopharmacology 2008, 33:3182-3189.
13. Chapman D.P., Whitfield C.L., Felitti V.J., Dube S.R., Edwards V.J., Anda R.F. Adverse childhood experiences and the risk of depressive disorders in adulthood. J. Affect. Disord. 2004, 82:217-225.
14. Cleare A.J. The HPA axis and the genesis of chronic fatigue syndrome. Trends Endocrinol. Metab. 2004, 15:55-59.
15. Dantzer R., O'Connor J.C., Lawson M.A., Kelley K.W. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 2011, 36:426-436.
16. De Bosscher K., Van Craenenbroeck K., Meijer O.C., Haegeman G. Selective transrepression versus transactivation mechanisms by glucocorticoid receptor modulators in stress and immune systems. Eur. J. Pharmacol. 2008, 583:290-302.
17. de Kloet C.S., Vermetten E., Bikker A., Meulman E., Geuze E., Kavelaars A., Westenberg H.G.M., Heijnen C.J. Leukocyte glucocorticoid receptor expression and immunoregulation in veterans with and without post-traumatic stress disorder. Mol. Psychiatry 2007, 12:443-453.
18. De Vries M., Soetekouw P.M.M.B., Van Der Meer J.W.M., Bleijenberg G. Fatigue in Cambodia veterans. QJM 2000, 93:283-289.
19. de Vries M., Soetekouw P.M., van der Meer J.W., Bleijenberg G. The role of post-traumatic stress disorder symptoms in fatigued Cambodia veterans. Mil. Med. 2002, 167:790-794.
20. Delahanty D.L. Toward the predeployment detection of risk for PTSD. Am. J. Psychiatry 2011, 168:9-11.
21. Gaab J., Rohleder N., Heitz V., Schad T., Engert V., Schurmeyer T., Ehlert U. Enhanced glucocorticoid sensitivity in patients with chronic fatigue syndrome. Acta Neuropsychiatrica 2003, 15:184-191.
22. Gill J., Luckenbaugh D., Charney D., Vythilingam M. Sustained elevation of serum interleukin-6 and relative insensitivity to hydrocortisone differentiates posttraumatic stress disorder with and without depression. Biol. Psychiatry 2010, 68:999-1006.
23. Gros D.F., Simms L.J., Acierno R. Specificity of posttraumatic stress disorder symptoms: an investigation of comorbidity between posttraumatic stress disorder symptoms and depression in treatment-seeking veterans. J. Nerv. Ment. Dis. 2010, 198:885-890.
24. Gross K.L., Cidlowski J.A. Tissue-specific glucocorticoid action: a family affair. Trends Endocrinol. Metab. 2008, 19:331-339.
25. Heijnen C.J. Receptor regulation in neuroendocrine-immune communication: current knowledge and future perspectives. Brain Behav. Immun. 2007, 21:1-8.
26. Heim C., Nemeroff C.B. Neurobiology of posttraumatic stress disorder. CNS Spectr. 2009, 14:13-24.
27. Heim C., Ehlert U., Hellhammer D.H. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000, 25:1-35.
28. Heim C., Nater U.M., Maloney E., Boneva R., Jones J.F., Reeves W.C. Childhood trauma and risk for chronic fatigue syndrome: association with neuroendocrine dysfunction. Arch. Gen. Psychiatry 2009, 66:72-80.
29. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000, 23:477-501.
30. Hovens J.E., van der Ploeg H.M., Bramsen I., Klaarenbeek M.T.A., Schreuder J.N., Rivero V.V. The development of the self-rating inventory for posttraumatic stress disorder. Acta Psychiatr. Scand. 1994, 90:172-183.
31. Hovens J.E., Bramsen I., van der Ploeg H.M. Self-rating inventory for posttraumatic stress disorder: review of the psychometric properties of a new brief Dutch screening instrument. Percept. Mot. Skills 2002, 94:996-1008.
32. Ikin J.F., Creamer M.C., Sim M.R., McKenzie D.P. Comorbidity of PTSD and depression in Korean War veterans: prevalence, predictors, and impairment. J. Affect. Disord. 2010, 125:279-286.
33. Kang H.K., Natelson B.H., Mahan C.M., Lee K.Y., Murphy F.M. Post-traumatic stress disorder and chronic fatigue syndrome-like illness among Gulf War veterans: a population-based survey of 30,000 veterans. Am. J. Epidemiol. 2003, 157:141-148.
34. Kavelaars A., Kuis W., Knook L., Sinnema G., Heijnen C.J. Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome. J. Clin. Endocrinol. Metab. 2000, 85:692-696.
35. Kline R.B. Principles and Practice of Structural Equation Modeling 2005, Guilford Press, New York.
36. Lowy M.T., Reder A.T., Antel J.P., Meltzer H.Y. Glucocorticoid resistance in depression: the dexamethasone suppression test and lymphocyte sensitivity to dexamethasone. Am. J. Psychiatry 1984, 141:1365-1370.
37. Miller G.E., Freedland K.E., Carney R.M. Depressive symptoms and the regulation of proinflammatory cytokine expression in patients with coronary heart disease. J. Psychosom. Res. 2005, 59:231-236.
38. Miller G.E., Rohleder N., Stetler C., Kirschbaum C. Clinical depression and regulation of the inflammatory response during acute stress. Psychosom. Med. 2005, 67:679-687.
39. Miller G.E., Chen E., Fok A.K., Walker H., Lim A., Nicholls E.F., Cole S., Kobor M.S. Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:14716-14721.
40. Munck A., Naray-Fejes-Toth A. Glucocorticoids and stress: permissive and suppressive actions. Ann. N. Y. Acad. Sci. 1994, 746:115-130. (discussion 131-133).
41. Nater U.M., Lin J.M., Maloney E.M., Jones J.F., Tian H., Boneva R.S., Raison C.L., Reeves W.C., Heim C. Psychiatric comorbidity in persons with chronic fatigue syndrome identified from the Georgia population. Psychosom. Med. 2009, 71:557-565.
42. Pariante C.M., Miller A.H. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiatry 2001, 49:391-404.
43. Raison C.L., Miller A.H. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am. J. Psychiatry 2003, 160:1554-1565.
44. Rohleder N., Wolf J.M., Wolf O.T. Glucocorticoid sensitivity of cognitive and inflammatory processes in depression and posttraumatic stress disorder. Neurosci. Biobehav. Rev. 2010, 35:104-114.
45. Rohleder N., Joksimovic L., Wolf J.M., Kirschbaum C. Hypocortisolism and increased glucocorticoid sensitivity of pro-inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder. Biol. Psychiatry 2004, 55:745-751.
46. Schmitz N., Kruse J., Heckrath C., Alberti L., Tress W. Diagnosing mental disorders in primary care: the General Health Questionnaire (GHQ) and the Symptom Check List (SCL-90-R) as screening instruments. Soc. Psychiatry Psychiatr. Epidemiol. 1999, 34:360-366.
47. Silverman M.N., Heim C.M., Nater U.M., Marques A.H., Sternberg E.M. Neuroendocrine and immune contributors to fatigue. PM R 2010, 2:338-346.
48. Strik J.J., Honig A., Lousberg R., Denollet J. Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. Psychosomatics 2001, 42:423-428.
49. Tanke M.A., Bosker F.J., Gladkevich A.V., Medema H.M, den Boer J.A., Korf J. Lymphocyte glucocorticoid receptor resistance and depressive symptoms severity: a preliminary report. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1298-1301.
50. ter Wolbeek M., van Doornen L.J., Schedlowski M., Janssen O.E., Kavelaars A., Heijnen C.J. Glucocorticoid sensitivity of immune cells in severely fatigued adolescent girls: a longitudinal study. Psychoneuroendocrinology 2008, 33:375-385.
51. Thomas J.L., Wilk J.E., Riviere L.A., McGurk D., Castro C.A., Hoge C.W. Prevalence of mental health problems and functional impairment among active component and National Guard soldiers 3 and 12 months following combat in Iraq. Arch. Gen. Psychiatry 2010, 67:614-623.
52. van Zelst W.H., de Beurs E., Beekman A.T., Deeg D.J., Bramsen I., van Dyck R. Criterion validity of the self-rating inventory for posttraumatic stress disorder (SRIP) in the community of older adults. J. Affect. Disord. 2003, 76:229-235.
53. van Zuiden M., Geuze E., Maas M., Vermetten E., Heijnen C.J., Kavelaars A. Deployment-related severe fatigue with depressive symptoms is associated with increased glucocorticoid binding to peripheral blood mononuclear cells. Brain Behav. Immun. 2009, 23:1132-1139.
54. van Zuiden M., Geuze E., Willemen H.L., Vermetten E., Maas M., Heijnen C.J., Kavelaars A. Pre-existing high glucocorticoid receptor number predicting development of posttraumatic stress symptoms after military deployment. Am. J. Psychiatry 2011, 168:89-96.
55. van Zuiden M., Heijnen C.J., van de Schoot R., Amarouchi K., Maas M., Vermetten E., Geuze E., Kavelaars A. Cytokine production by leukocytes of military personnel with depressive symptoms after deployment to a combat-zone: a prospective, longitudinal study. Plos One 2011, 6:e29142.
56. van Zuiden M., Geuze E., Willemen H.L., Vermetten E., Maas M., Amarouchi K., Kavelaars A., Heijnen C.J. Glucocorticoid receptor pathway components predict Posttraumatic Stress Disorder symptom development: a prospective study. Biol. Psychiatry 2012, 71:309-316.
57. Vercoulen J.H.M.M., Alberts M., Bleijenberg G. The checklist individual strength. Gedragstherapie 1999, 32:131-136.
58. Visser J., Lentjes E., Haspels I., Graffelman W., Blauw B., de Kloet R., Nagelkerken L. Increased sensitivity to glucocorticoids in peripheral blood mononuclear cells of chronic fatigue syndrome patients, without evidence for altered density or affinity of glucocorticoid receptors. J. Investig. Med. 2001, 49:195-204.
59. Visser J., Blauw B., Hinloopen B., Brommer E., de Kloet E.R., Kluft C., Nagelkerken L. CD4 T lymphocytes from patients with chronic fatigue syndrome have decreased interferon-gamma production and increased sensitivity to dexamethasone. J. Infect. Dis. 1998, 177:451-454.
60. Wirtz P.H., von Kanel R., Schnorpfeil P., Ehlert U., Frey K., Fischer J.E. Reduced glucocorticoid sensitivity of monocyte interleukin-6 production in male industrial employees who are vitally exhausted. Psychosom. Med. 2003, 65:672-678.
61. Yehuda R., Yang R.K., Golier J.A., Grossman R.A., Bierer L.M., Tischler L. Effect of sertraline on glucocorticoid sensitivity of mononuclear leukocytes in post-traumatic stress disorder. Neuropsychopharmacology 2006, 31:189-196.
62. Yehuda R., Golier J.A., Yang R., Tischler L. Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder. Biol. Psychiatry 2004, 55:1110-1116.